Innovation in Ireland →
Founder, Gilt Groupe
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Professor of Systems Biology, Columbia University
Managing Director, D.E. Shaw and Co., L.P.
CEO and Fund Manager, Renaissance Venture Capital Fund
VP of Research & Policy, Ewing Marion Kauffman Foundation
VP of Venture Capital, Pfizer Inc.
Thrombolytic Science International is developing a stroke treatment.
Boston · 03/11/15
1:00 - 5:00 pm
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2015, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.